tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market

ARS Pharmaceuticals (SPRY) Technical Analysis

Compare
383 Followers

Technical Sentiment

Overall Consensus
Strong Buy
14Bullish
6Neutral
2Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is 0.41, suggesting ARS Pharmaceuticals is a Buy.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 13.89, while ARS Pharmaceuticals’s (SPRY) share price is $14.46, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 13.20, while ARS Pharmaceuticals’s (SPRY) share price is $14.46, making it a Buy.

ARS Pharmaceuticals (SPRY) Pivot Points

May 03, 2025, 03:40 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.11
13.33
13.65
13.87
14.19
14.41
14.73
Fibonacci
13.33
13.54
13.66
13.87
14.08
14.20
14.41
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

May 03, 2025, 03:40 PM
Period
Simple
Exponential
MA5
13.99Buy
14.11Buy
MA10
14.32Sell
14.14Buy
MA20
13.98Buy
13.89Buy
MA50
12.59Buy
13.20Buy
MA100
12.41Buy
12.84Buy
MA200
12.93Buy
12.34Buy
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 14.14, while ARS Pharmaceuticals’s (SPRY) share price is $14.46, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 12.84, while ARS Pharmaceuticals’s (SPRY) share price is $14.46, making it a Buy.
ARS Pharmaceuticals’s (SPRY) stock price is $14.46 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 12.59, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $14.46 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 12.41, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $14.46 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 12.93, creating a Buy signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

May 03, 2025, 03:40 PM
Name
Value
Implied Action
RSI (14)
54.71
Neutral
STOCH (9,6)
24.17
Neutral
STOCHRSI (14)
48.30
Neutral
MACD (12,26)
0.41
Buy
ADX (14)
25.87
Neutral
Williams %R
-57.66
Buy
CCI (14)
1.39
Neutral
ATR (14)
0.86
-
Ultimate Oscillator
51.54
Neutral
ROC
6.95
Buy
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 54.71, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 25.87, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is 1.39, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is 6.95, creating a Buy signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Strong Buy.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 54.71, which suggests SPRY is a Neutral.
      What is SPRY’s MACD?
      SPRY’s MACD is 0.41, which suggests SPRY is a Buy.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 13.99, which suggests SPRY is a Buy.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 13.98, which suggests SPRY is a Buy.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 12.59, which suggests SPRY is a Buy.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 12.93, which suggests SPRY is a Buy.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -57.66, which suggests SPRY is a Buy.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is 1.39, which suggests SPRY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis